Intercostal Nerve Block for Pain Management After Uniportal Video-assisted Thoracoscopic Surgeries
Launched by AL-QUDS UNIVERSITY · Feb 18, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different methods of managing pain after a specific type of surgery called uniportal video-assisted thoracoscopic surgery (VATS), which is done through one small opening in the chest. The researchers want to see how effective and safe three types of pain relief techniques are: internal intercostal nerve blocks, external intercostal nerve blocks, and intercostal catheters. Participants will be randomly placed into one of these three groups to compare how well each method works for reducing pain after surgery.
To be eligible for this trial, you need to be between 18 and 80 years old and scheduled for elective or urgent uniportal VATS. However, if you are under 18, over 80, or have certain health issues like chest infections or severe kidney problems, you won't be able to participate. If you join, you can expect to receive one of the pain management techniques and help researchers understand which option provides the best pain relief. Additionally, it's important to know that if there are any issues during the procedure, you may be withdrawn from the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All participants between the ages of 18 and 80 year-old who have elective or urgent uniportal VATS will be included in the sample.
- Exclusion Criteria:
- • Children - under the age of 18 or participants above the age of 80.
- • Participants with chest wall infections and those with decorticated lungs will be excluded from the study.
- • Participants with pre-existing chest pain or severe renal or hepatic dysfunction
- • Participants with a history of psychiatric disorder or inability to understand the consent form or how to use a Numerical Rating Scale (NRS) for pain measurement
- • Participants who have allergy to any of the given drugs, second thoracic surgery, participation in other clinical trials, obesity with body mass index\>35 kg/m2, intake of antiplatelet or anticoagulant agents, spinal deformity and severe bradycardia will also be excluded.
- • Participants will be withdrawn from the study if the technical failure happened in the block or VATS procedure was converted to open procedure.
About Al Quds University
Al-Quds University is a leading academic institution located in Palestine, dedicated to advancing research and education in various fields, including health sciences. The university is committed to fostering innovative clinical research that addresses local and global health challenges. By leveraging its multidisciplinary expertise and collaboration with healthcare professionals, Al-Quds University aims to contribute to evidence-based practices and improve patient outcomes through rigorous clinical trials. With a focus on ethical standards and community engagement, the university strives to enhance the quality of life for diverse populations through its research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hebron, , Palestinian Territory, Occupied
East Jerusalem, , Palestinian Territory, Occupied
Patients applied
Trial Officials
Yousef Abu Asabeh, M.D.
Study Chair
Thoracic Surgery Department, Al-Ahli Hospital, Palestine
Mayar Idkedek, M.D.
Study Director
Medical Research Club, Faculty of Medicine, Al-Quds University, Jerusalem, Palestine
Tabarak Al-Masri, M.D.
Principal Investigator
Medical Research Club, Faculty of Medicine, Al-Quds University, Jerusalem, Palestine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported